GoodRx could seek up to $969M in IPO
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.
Report: GoodRx files for IPO
GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The company reportedly submitted paperwork to the Securities and Exchange Commission.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.